Treating the patient or the population? Part 1. Judging the benefit of treatment of individual patients.
作者信息
Heller T D, Heller R F, Pattison S, Fletcher R
机构信息
School of Health and Social Welfare Open University Walton Hall Milton Keynes MK7 6AA, UK.
出版信息
West J Med. 2001 Jul;175(1):35-7. doi: 10.1136/ewjm.175.1.35.
Abstract
摘要
相似文献
1
Treating the patient or the population? Part 1. Judging the benefit of treatment of individual patients.
West J Med. 2001 Jul;175(1):35-7. doi: 10.1136/ewjm.175.1.35.
2
Treating hypercholesterolemia--without the hype.
Am J Cardiol. 1997 Apr 1;79(7):1001-3.
3
Goals of statin conversion program.
Am J Health Syst Pharm. 2002 Feb 15;59(4):380-1. doi: 10.1093/ajhp/59.4.380.
4
Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study.
Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):287-96. doi: 10.1177/1741826710389366. Epub 2011 Jan 31.
5
The cost of simvastatin therapy in treatment of hypercholesterolaemia in a hospital lipid clinic.
Med J Aust. 1992 Apr 6;156(7):510.
6
What is the role of PCSK9 inhibitors in treating hypercholesterolemia?
JAAPA. 2018 Jun;31(6):14-15. doi: 10.1097/01.JAA.0000532126.38283.02.
7
CEPHEUS Trial.
Arch Cardiovasc Dis. 2008 Sep;101(9):513-4. doi: 10.1016/j.acvd.2008.09.002. Epub 2008 Nov 6.
8
[The drug therapy of hypercholesterolemia].
Dtsch Med Wochenschr. 1996 May 31;121(22):729-34. doi: 10.1055/s-2008-1043062.
9
10
An interactive computer system for formulary management using cost-effectiveness analysis.
MD Comput. 1995 Jan-Feb;12(1):59-65.
本文引用的文献
1
Effective use of statins to prevent coronary heart disease.
Am Fam Physician. 2001 Jan 15;63(2):309-20, 323-4.
2
Tell it like it is: patients as partners in medical decision making.
J Gen Intern Med. 2000 Oct;15(10):752-4. doi: 10.1046/j.1525-1497.2000.00815.x.
3
The cost-effectiveness of lipid lowering in patients with ischaemic heart disease: an intervention and evaluation in primary care.
Br J Gen Pract. 2000 Sep;50(458):699-705.
4
Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.
BMJ. 2000 Oct 21;321(7267):983-6. doi: 10.1136/bmj.321.7267.983.
5
Statins: underused by those who would benefit.
BMJ. 2000 Oct 21;321(7267):971-2. doi: 10.1136/bmj.321.7267.971.
6
Primary prevention of coronary heart disease in women through diet and lifestyle.
N Engl J Med. 2000 Jul 6;343(1):16-22. doi: 10.1056/NEJM200007063430103.
7
Sex differences in cardiovascular disease: are women with low socioeconomic status at high risk?
Br J Gen Pract. 1999 Dec;49(449):963-6.
8
Paternalism or partnership? Patients have grown up-and there's no going back.
BMJ. 1999 Sep 18;319(7212):719-20. doi: 10.1136/bmj.319.7212.719.
9
Barriers to referral in patients with angina: qualitative study.
BMJ. 1999 Aug 14;319(7207):418-21. doi: 10.1136/bmj.319.7207.418.
10
Sharing decisions with patients: is the information good enough?
BMJ. 1999 Jan 30;318(7179):318-22. doi: 10.1136/bmj.318.7179.318.
Zotero 插件